510(k) Report

510(k) · Cleared

Recalled · 2011

Variant II Turbo Link Hemoglobin A1C Program, and Variant II Turbo Link Hemoglobin Testing with Model, 270-2716,

K070819510(k) TraditionalCleared Jun 25, 200791-day reviewClass II21 CFR 864.7470Recalls 5

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories Inc., Clinical Systems Divisi · LCP Assay, Glycosylated Hemoglobin

Cleared on Jun 25, 2007 as substantially equivalent to K040872 (Bio-Rad Laboratories, Inc., 2004) and 1 other predicate after a 91-day review. Its family tree reaches back 4 generations to 1993. 1 later device descends from it. It has been recalled 5 times.

Decided
Jun 25, 2007
Review
91 days
Class
Class II
Product code
LCP
Recalls
5
Predicates
2

Its longest line of descent runs back 4 generations to K926469 (1993). 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK926469 Variant (TM) Hemoglobin a 1C ProgramBio-Rad · 1993
  2. 3 generations backK984268 Variant II Hemoglobin A1C ProgramBio-Rad · 1998 · Recalled
  3. 2 generations backK040872 Variant II Hemoglobin A1CBio-Rad Laboratories, Inc. · 2004 · Recalled
  4. 1 generation backK063400 Variant II Turbo Hemoglobin A1C Program, Hemoglobin Testing System…Bio-Rad Laboratories, Inc. · 2006 · Recalled
  5. This deviceK070819 Variant II Turbo Link Hemoglobin A1C Program, and Variant II Turbo…Bio-Rad Laboratories Inc., Clinical Systems Divisi · 2007
  6. Descendant · cites it directly · 0 of its ownK140801 Variant II Turbo Link Hemoglobin A1C Program/Testing SystemBio-Rad Laboratories, Inc. · 2014

Most influential descendants

Showing 1 of 1 · See all
  • K140801Variant II Turbo Link Hemoglobin A1C Program/Testing SystemBio-Rad Laboratories, Inc. · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K926469Variant (TM) Hemoglobin a 1C ProgramBio-Rad1993—
−3K984268Variant II Hemoglobin A1C ProgramBio-Rad19982
−2K040872Variant II Hemoglobin A1CBio-Rad Laboratories, Inc.20044
−1K063400Variant II Turbo Hemoglobin A1C Program, Hemoglobin Testing System with CDM 4.0Bio-Rad Laboratories, Inc.20064
0 (this device)K070819Variant II Turbo Link Hemoglobin A1C Program, and Variant II Turbo Link…Bio-Rad Laboratories Inc., Clinical Systems Divisi2007—
+1K140801Variant II Turbo Link Hemoglobin A1C Program/Testing SystemBio-Rad Laboratories, Inc.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
FIG. 1 — Lineage of K070819, 1993–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LCP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LCP device

  1. #1 K221326 Nova Allegro HbA1c Assay, Nova Allegro Analyzerscore 9.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040872Variant II Hemoglobin A1C
Summary page 2
…ycosylated Hemoglobin, 81LCP Predicate Device(s): VARIANTTM II TURBO Hemoglobin A c Program (k) 040872 Bio-Rad Laboratories, Inc. VARIANT…
Bio-Rad Laboratories, Inc.20044
*K063400Variant II Turbo Hemoglobin A1C Program, Hemoglobin Testing System with CDM 4.0
Summary page 2
…gram run on the VARIANT II TURBO Hemoglobin Testing System with CDM 4.0 (k) 063400 Bio-Rad Laboratories, Inc. Intended Use: The Bio…
Bio-Rad Laboratories, Inc.20064

Also cleared against K040872: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140801Variant II Turbo Link Hemoglobin A1C Program/Testing SystemBio-Rad Laboratories, Inc.20140

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 25, 2011Not classifiedZ-0399-2012Process controlIt was discovered that the Variant II Turbo Link Calibrator Values card contains incorrect values for IFCC units. The numbers are missing a decimal point.
Sep 12, 2011Not classifiedZ-0027-2012Process controlA previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these…
Sep 12, 2011Not classifiedZ-0026-2012Process controlA previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these…
Jul 28, 2011Not classifiedZ-3159-2011Employee errorThe Elution Buffer B, lot no. GA 10430, was shipped in a 2.0 L bottle instead of the standard 2.5 L bottle.
Feb 19, 2010Not classifiedZ-1259-2011Nonconforming Material/ComponentThe results from the blood device had the occurrence of some ramping baselines on their chromatograms. The ramping baseline can affect quantitation of the blood results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 5.3 years on median.
  • 3 of the 4 ancestors have a recall of any class.
  • Of its descendants, K140801 (Bio-Rad Laboratories, Inc., 2014) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K040872.

How does its category compare?

All LCP devices

LCP Assay, Glycosylated Hemoglobin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LCP

1in 2024

2007: 72008: 52009: 62010: 22011: 102012: 92013: 22014: 82015: 32016: 22017: 52018: 22019: 42020: 12023: 22024: 1
2007high 10 (2011) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LCP

269in 2019

2007: 133 days median2008: 206 days median2009: 158 days median2011: 176 days median2012: 143 days median2014: 127 days median2015: 239 days median2017: 218 days median2019: 269 days median
2007high 269 (2019) · low 127 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LCP

1in 2025

2007: 12008: 32009: 62010: 52011: 512013: 42014: 22015: 22016: 62017: 12018: 12022: 12024: 12025: 1
2007high 51 (2011) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LCP

22in 2025

2007: 52008: 112009: 152010: 42011: 272012: 512013: 1932014: 1822015: 642016: 292017: 1492018: 1,9112019: 1142020: 132021: 72022: 82023: 272024: 392025: 22
2007high 1,911 (2018) · low 4 (2010)2025

MAUDE reports naming product code LCP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007713315
20085206311
20096158615
20102—54
2011101765127
20129143051
20132—4193
201481272182
20153239264
20162—629
201752181149
20182—11,911
201942690114
20201—013
20210—07
20220—18
20232—027
20241—139
20250—122
20260—0—

What is it indicated for?

The Bio-Rad VARIANT IITURBO Link Hemoglobin Alc Program is intended for the percent determination of hemoglobin Alc in human whole blood using ion-exchange high-performance liquid chromatography (HPLC). Measurement of percent hemoglobin Al c is effective in monitoring long-term glucose control in individuals with diabetes mellitus.

The VARIANT IITURBO Link Hemoglobin Alc Program is for use with the VARIANT II TURBO Link Hemoglobin Testing System interfaced with an automated sample transport system.

The Bio-Rad VARIANT IITURBO Link Hemoglobin Alc Program is intended for Professional Use Only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070819: Variant II Turbo Link Hemoglobin A1C Program, and Variant II Turbo Link Hemoglobin Testing with Model, 270-2716,.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070819

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026